A randomized, controlled study of once-daily LY2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin-treated patients with type 2 diabetes Journal Article uri icon
Overview
abstract

  • OBJECTIVE: To evaluate whether LY2605541 results in lower fasting blood glucose (FBG) versus insulin glargine (GL). RESEARCH DESIGN AND METHODS: This 12-week, randomized, open-label, Phase 2 study enrolled patients with type 2 diabetes (hemoglobin A(1c) [A1C]

    • Link to Article
    authors
    publication date
  • 2012
    • published in
  • Diabetes care  Journal
    • Research
    keywords
  • Diabetes
  • Drugs and Drug Therapy
  • Randomized Controlled Trials
    • Additional Document Info
    volume
  • 35
    • issue
  • 11